PRESS RELEASE: SANOFI’S MENQUADFI APPROVED IN THE EU FOR USE IN INFANTS FROM AGE SIX WEEKS AGAINST INVASIVE MENINGOCOCCAL DISEASE

Reuters · 2d ago

Please log in to view news